Development
Vicarious Surgical Inc.
RBOT
$7.58
-$0.07-0.92%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -8.54% | -3.50% | 24.33% | 60.91% | 123.80% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.96% | 10.11% | 35.89% | 64.57% | 109.50% |
| Operating Income | 0.96% | -10.11% | -35.89% | -64.57% | -109.50% |
| Income Before Tax | -1,478.15% | -281.36% | -540.76% | -612.25% | 114.65% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,478.15% | -281.36% | -540.76% | -612.25% | 114.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,478.15% | -281.36% | -540.76% | -612.25% | 114.65% |
| EBIT | 0.96% | -10.11% | -35.89% | -64.57% | -109.50% |
| EBITDA | 1.92% | -9.05% | -34.57% | -63.36% | -108.31% |
| EPS Basic | -1,156.31% | -263.44% | -1,877.34% | -1,732.86% | 110.94% |
| Normalized Basic EPS | -1,142.52% | -262.29% | -1,883.18% | -1,732.20% | 110.90% |
| EPS Diluted | -2,165.59% | -276.38% | -5,855.96% | -808.41% | 105.52% |
| Normalized Diluted EPS | -1,903.45% | -273.23% | -4,318.28% | -966.78% | 106.30% |
| Average Basic Shares Outstanding | 19.77% | 10.16% | 10.07% | 17.51% | 25.96% |
| Average Diluted Shares Outstanding | 18.00% | 8.52% | 8.32% | 15.50% | 27.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |